To examine this, the inhibitor of HMGB1, ethyl pyruvate (EP), and the inhibitor of ROS, NAC, were administrated individually or together to hepatoma-bearing mice (Fig. 6e). Here, HMGB1 is linked to hepatocellular carcinoma.